1. Home
  2. FTEL vs LUNG Comparison

FTEL vs LUNG Comparison

Compare FTEL & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTEL
  • LUNG
  • Stock Information
  • Founded
  • FTEL 2007
  • LUNG 1995
  • Country
  • FTEL Australia
  • LUNG United States
  • Employees
  • FTEL N/A
  • LUNG N/A
  • Industry
  • FTEL
  • LUNG Industrial Specialties
  • Sector
  • FTEL
  • LUNG Health Care
  • Exchange
  • FTEL Nasdaq
  • LUNG Nasdaq
  • Market Cap
  • FTEL 215.1M
  • LUNG 256.3M
  • IPO Year
  • FTEL 2023
  • LUNG 2020
  • Fundamental
  • Price
  • FTEL $9.90
  • LUNG $6.23
  • Analyst Decision
  • FTEL
  • LUNG Buy
  • Analyst Count
  • FTEL 0
  • LUNG 6
  • Target Price
  • FTEL N/A
  • LUNG $11.92
  • AVG Volume (30 Days)
  • FTEL 319.3K
  • LUNG 214.3K
  • Earning Date
  • FTEL 11-15-2024
  • LUNG 02-19-2025
  • Dividend Yield
  • FTEL N/A
  • LUNG N/A
  • EPS Growth
  • FTEL N/A
  • LUNG N/A
  • EPS
  • FTEL N/A
  • LUNG N/A
  • Revenue
  • FTEL $4,466,775.00
  • LUNG $79,302,000.00
  • Revenue This Year
  • FTEL N/A
  • LUNG $22.26
  • Revenue Next Year
  • FTEL N/A
  • LUNG $18.72
  • P/E Ratio
  • FTEL N/A
  • LUNG N/A
  • Revenue Growth
  • FTEL N/A
  • LUNG 22.34
  • 52 Week Low
  • FTEL $2.32
  • LUNG $5.46
  • 52 Week High
  • FTEL $49.50
  • LUNG $14.84
  • Technical
  • Relative Strength Index (RSI)
  • FTEL 42.93
  • LUNG 41.35
  • Support Level
  • FTEL $9.38
  • LUNG $6.24
  • Resistance Level
  • FTEL $11.15
  • LUNG $7.27
  • Average True Range (ATR)
  • FTEL 1.34
  • LUNG 0.39
  • MACD
  • FTEL 0.78
  • LUNG -0.06
  • Stochastic Oscillator
  • FTEL 72.68
  • LUNG 2.52

About FTEL Fitell Corporation

Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

Share on Social Networks: